Bayer Still Faces 4,000 Yaz and Yasmin Lawsuits, Even After $2B in Settlements

Bayer Healthcare has paid $2 billion in Yaz and Yasmin settlements to resolve lawsuits over side effects of their popular birth control drugs. However, the company recently disclosed that there are still several thousand additional complaints pending from users who suffered severe and sometimes fatal injuries.

In an investor report issued this week for the second quarter of 2015, Bayer indicates that even after settling about 9,900 Yaz lawsuits, Yasmin lawsuits and other claims over birth control drugs containing drospirenone, about 4,000 claims remain unresolved.

All of the lawsuits involve similar allegations that Bayer failed to adequately warn women and the medical community about the potential side effects of Yaz and Yasmin, after the active ingredient drospirenone has been linked to an increased risk of blood clots, heart attacks, strokes and other injuries.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Bayer indicates that it has paid $1.97 billion to resolve claims involving venous clot injuries, such as deep vein thrombosis or pulmonary embolism. Another $57 million will be paid to resolve Yaz gallbladder injuries.

As of July 17, about 1,200 of the remaining 4,000 claims involve arterial thromboembolic injuries, which the drug maker has previously indicated that it is not currently willing to settle.

Since October 2009, the federal Yaz and Yasmin litigation has been consolidated for pretrial proceedings before U.S. District Judge David R. Herndon in the Southern District of Illinois. At its peak, the litigation involved more than 12,000 complaints.

Due to a lack of progress in settling this last group of Yaz and Yasmin cases, Judge Herndon has indicated that he may begin remanding individual cases back to the U.S. District Court where they were originally filed for individual trial dates.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted today)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted yesterday)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.

Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children
Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children (Posted 4 days ago)

Plaintiffs have submitted a baby food lawsuit Master Complaint that is expected to streamline the filing of lawsuits alleging that toxic heavy metals in Beech-Nut, Gerber, Hain and Nurture products caused ADHD, autism and other developmental disorders.